(11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

12 Suppliers, 6 USDMF, 2 CEP/COS, 1 EU WC, 1 KDMF, 8 NDC API, 8 Listed Suppliers

DEVELOPMENTS

4 Drug(s) in Development

4 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

DOSSIERs // Finished Dosage Forms

16 Dossiers, 6 FDA Orange Book, 4 Europe, 1 Canada, 2 Australia, 1 South Africa, 2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

Suppliers, 24 Kerry, 16 Roquette, 12 Sigachi Industries, 10 Microlex e.U, 9 Gangwal Healthcare, 7 DFE Pharma, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 Gangwal Chemicals, 4 Prachin Chemical, 4 Ingredion Pharma Solutions, 4 SPI Pharma, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Vasa Pharmachem, 2 Pharmatrans-Sanaq, 1 Aeon Procare, 1 Nanjing Well Pharmaceutical, 1 Ideal Cures Pvt Ltd, 1 Jai Radhe Sales, 1 DKSH, 1 Seppic

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders, 28 Disintegrants & Superdisintegrants, 25 Direct Compression, 13 Granulation, 13 Lubricants & Glidants, 11 Co-Processed Excipients, 11 Thickeners and Stabilizers, 6 Controlled & Modified Release, 5 Chewable & Orodispersible Aids, 5 Taste Masking, 4 Coating Systems & Additives, 2 Rheology Modifiers, 2 Film Formers & Plasticizers, 1 Emulsifying Agents, 1 Parenteral

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 3 Finished Drug Prices

MARKET PLACE

6 APIs, 3 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

2 EDQM Standards, 1 USP Standards, 2 JP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

5 News

5 News

(11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl Acetate
FDA Orange Book
Full Screen View

Approved Drug Products containing (11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate listed in the FDA Orange Book. Original Data : FDA Website

(11beta)-9-fluoro-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl acetate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

12 Suppliers

6 USDMF

2 CEP/COS

1 EU WC

1 KDMF

8 NDC API

8 Listed Suppliers

DEVELOPMENTS

4 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

DOSSIERs // Finished Dosage Forms

16 Dossiers

6 FDA Orange Book

4 Europe

1 Canada

2 Australia

1 South Africa

2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

Suppliers

24 Kerry

16 Roquette

12 Sigachi Industries

10 Microlex e.U

9 Gangwal Healthcare

7 DFE Pharma

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 Gangwal Chemicals

4 Prachin Chemical

4 Ingredion Pharma Solutions

4 SPI Pharma

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Vasa Pharmachem

2 Pharmatrans-Sanaq

1 Aeon Procare

1 Nanjing Well Pharmaceutical

1 Ideal Cures Pvt Ltd

1 Jai Radhe Sales

1 DKSH

1 Seppic

EXCIPIENTS BY APPLICATIONS

54 Fillers, Diluents & Binders

28 Disintegrants & Superdisintegrants

25 Direct Compression

13 Granulation

13 Lubricants & Glidants

11 Co-Processed Excipients

11 Thickeners and Stabilizers

6 Controlled & Modified Release

5 Chewable & Orodispersible Aids

5 Taste Masking

4 Coating Systems & Additives

2 Rheology Modifiers

2 Film Formers & Plasticizers

1 Emulsifying Agents

1 Parenteral

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions

3 Finished Drug Prices

MARKET PLACE

6 APIs

3 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

2 EDQM Standards

1 USP Standards

2 JP Standards

1 Other Ref. Standards

DIGITAL CONTENT

5 News

TABLET;ORAL

0.1MG

2022-05-31

0.1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons